HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials
On Jul. 19, 2020, HDT Bio announced co-development efforts with Gennova Biopharmaceuticals to start evaluating HDT-301, a COVID-19 vaccine, in human clinical trials.
Tags:
Source: HDT Bio
Credit:
